[Clinical analysis of 13 cases of embryonal rhabdomyosarcoma in the nose].
OBJECTIVE
To better understand the embryonal rhabdomyosarcoma of nose and make correct decision for diagnosis and treatment.


METHODS
Thirteen patients with rhabdomyosarcoma in the nose were studied retrospectively and the related literature was reviewed.


RESULTS
Male predilection for the disease was present. One patient was in stage I, four patients were in stage II, seven patients were in stage III and one patients was in stage IV. Nine patients were operated plus chemotherapy and radiotherapy, one was operated together with radiotherapy, one was treated by radiotherapy and chemotherapy and the other two were treated by operation alone. The survival rate of two years was 69.2% (9/13), survival rate of 3 years was 30.8% (5/13).


CONCLUSIONS
The pathological growth form of embryonal rhabdomyosarcoma in nose is often convert. If the diagnosis are under suspicion, pathological or immunohistochemical examination should be taken in time. Early diagnosis and combined therapy will make contribution to better prognosis. Surgery combined with radiotherapy and chemotherapy can improve the survival rate.
Wu
Xin
X
Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li
Ping
P
Xie
Li
L
Zhang
Xiaoyu
X
Wang
Weiya
W
Xiao
Jianghong
J
Wang
Feng
F
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009669:Nose Neoplasms / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies; D018233:Rhabdomyosarcoma, Embryonal / Q000175:diagnosis / Q000628:therapy; D055815:Young Adult